| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United Kingdom | 21 | |
| #2 | Australia | 9 | |
| #3 | WIPO (World Intellectual Property Organization) | 9 | |
| #4 | Canada | 8 | |
| #5 | China | 8 | |
| #6 | EPO (European Patent Office) | 8 | |
| #7 | United States | 8 | |
| #8 | Mexico | 5 | |
| #9 | Norway | 5 | |
| #10 | New Zealand | 5 | |
| #11 | Taiwan | 5 | |
| #12 | South Africa | 5 | |
| #13 | Argentina | 4 | |
| #14 | Poland | 4 | |
| #15 | Republic of Korea | 3 | |
| #16 | Brazil | 2 | |
| #17 | Hong Kong | 2 | |
| #18 | Hungary | 2 | |
| #19 | Israel | 2 | |
| #20 | Japan | 1 | |
| #21 | Malaysia | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Foods and drinks | |
| #4 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Heterocyclic compounds | |
| #3 | Medical preparations | |
| #4 | Acyclic or carbocyclic compounds | |
| #5 | Foods | |
| #6 | Unspecified technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Palmer Richard Michael John | 62 |
| #2 | Hodson Harold Francis | 33 |
| #3 | Dunk Christopher Robert | 29 |
| #4 | Downham Robert | 23 |
| #5 | Knight John | 19 |
| #6 | Mitchell Timothy John | 18 |
| #7 | Meyers Nicholas Leslie | 17 |
| #8 | Carr Beverley Jane | 17 |
| #9 | Pusztai Arpad Janos | 15 |
| #10 | Fish Neil William | 15 |
| Publication | Filing date | Title |
|---|---|---|
| GB0329319D0 | Synthesis | |
| GB0321091D0 | Synthesis | |
| HU0401298A2 | Thieno [1,3] oxazin-4-ones with lipase inhibiting activity, process for their preparation and pharmaceutical compositions containing them | |
| GB0206031D0 | Inhibitors | |
| GB0203421D0 | Composition | |
| GB0121019D0 | /nhibitors | |
| GB0101135D0 | Inhibitors | |
| GB0101134D0 | Inhibitors | |
| GB0029730D0 | Inhibitors | |
| GB0029733D0 | Inhibitors | |
| ZA200003398B | Inhibitors. | |
| ZA200003399B | Inhibitors. | |
| GB0015996D0 | Inhibitors | |
| TWI295289B | 2-amino-benzoxazinone compounds for use as enzyme inhibitors | |
| GB0001572D0 | Inhibitors | |
| NZ512740A | 2-oxy-benzoxazinone derivatives for the treatment of obesity | |
| GB9929341D0 | Inhibitors | |
| GB9929340D0 | Inhibitors | |
| GB9917294D0 | Inhibitors | |
| GB9900416D0 | Inhibitors |